Jan 22, 2018 | Classic, Media, News, publication, Science in Society, Synthetic Biology
In a recent guest blog in Nature biotechnology’s Bioentrepreneur Trade Secrets, Markus Schmidt reported about the latest developments in designing novel vaccines. The reprogramming of Mycoplasma bacteria from pathogens to vaccines is only made possible thanks to...